4//SEC Filing
GOLDWYN MARTIN M 4
Accession 0000945769-12-000004
CIK 0000887497other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 6:08 PM ET
Size
27.0 KB
Accession
0000945769-12-000004
Insider Transaction Report
Form 4
GOLDWYN MARTIN M
Director
Transactions
- Sale
Common Stock
2012-07-16$29.83/sh−1,956$58,347→ 0 total - Sale
Common Stock
2012-07-16$32.11/sh−4,000$128,440→ 0 total - Exercise/Conversion
Common Stock
2012-07-17$14.99/sh+401$6,011→ 401 total - Sale
Common Stock
2012-07-17$32.05/sh−401$12,852→ 0 total - Exercise/Conversion
Common Stock
2012-07-16$14.99/sh+4,000$59,960→ 4,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−1,406→ 2,832 totalExercise: $8.31From: 2003-12-05Exp: 2012-12-05→ Common Stock (1,406 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-16−1,956→ 7,419 totalExercise: $13.50From: 2004-11-28Exp: 2013-11-28→ Common Stock (1,956 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-17−401→ 6,849 totalExercise: $14.99From: 2007-11-09Exp: 2016-11-09→ Common Stock (401 underlying) - Exercise/Conversion
Common Stock
2012-07-13$8.31/sh+1,406$11,684→ 1,406 total - Other
Common Stock
2012-07-13−1,406→ 0 total - Exercise/Conversion
Common Stock
2012-07-16$13.50/sh+1,956$26,406→ 1,956 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-16−4,000→ 7,250 totalExercise: $14.99From: 2007-11-09Exp: 2016-11-09→ Common Stock (4,000 underlying) - Award
Stock Option (Right to Buy)
2012-07-16+10,000→ 10,000 totalExercise: $32.59From: 2013-07-16Exp: 2022-07-16→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]The shares acquired upon exercise of the options reflected on this form were immediately distributed without consideration to a member or members of Mr. Goldwyn's law firm.
- [F2]The shares noted in this transaction were sold in two lots of 2,000 shares each, at $32.02 per share and $32.20 per share, respectively. The weighted average price per share is $32.11.
- [F3]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
- [F4]The option became or becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F5]Other than the options to acquire an aggregate of 27,100 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 61,748 shares of the Company's stock (for total options to acquire an aggegate of 88,848 shares held by the filer). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.
Documents
Issuer
HI TECH PHARMACAL CO INC
CIK 0000887497
Entity typeother
Related Parties
1- filerCIK 0001186837
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 6:08 PM ET
- Size
- 27.0 KB